FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pharmakon Pharmaceuticals Glycopyrrolate 0 Recall

Glycopyrrolate 0

Pharmakon Pharmaceuticals · Noblesville, IN

Risk level
Class II
Reported by FDA
Sep 3, 2014
Recall ID
D-1567-2014
Check your lot numberHow we source this data

Summary

Pharmakon Pharmaceuticals recalled Glycopyrrolate 0 starting Apr 21, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1567-2014 on Sep 3, 2014. Reason: Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. Status: Terminated.

Why it was recalled

Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.

Product description

Glycopyrrolate 0.2 mg/ml, 5 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd., Noblesville, IN 46060, NDC#: 45183-0965-70.

Lot numbers, UPCs & expiration codes

Lot #: E131210.212 Exp: 07/14/2014

Where it was sold

United States: TX, IL, MD, IN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1567-2014
Classification
Class II
Status
Terminated
Recall initiated
Apr 21, 2014
FDA report date
Sep 3, 2014
Quantity
200 Syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Pharmakon Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-1567-2014, exactly as published.

Show all FDA fields
City
Noblesville
State
IN
Status
Terminated
Country
United States
Event ID
68191
Address
14450 Getz Rd
Code information
Lot #: E131210.212 Exp: 07/14/2014
Postal code
46060-3303
Report date
Sep 3, 2014
Product type
Drugs
Recall number
D-1567-2014
Classification
Class II
Recalling firm
Pharmakon Pharmaceuticals
Product quantity
200 Syringes
Termination date
Dec 3, 2014
Reason for recall
Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Glycopyrrolate 0.2 mg/ml, 5 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd., Noblesville, IN 46060, NDC#: 45183-0965-70.
Distribution pattern
United States: TX, IL, MD, IN
Recall initiation date
Apr 21, 2014
Initial firm notification
Telephone
Center classification date
Aug 26, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1567-2014, published Sep 3, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls